Combination therapy in hormone-refractory prostate cancer

被引:0
|
作者
Daniel P. Petrylak
机构
关键词
Prostate Cancer; Hydrocortisone; Docetaxel; Mitoxantrone; Estramustine;
D O I
10.1007/s11912-001-0033-4
中图分类号
学科分类号
摘要
引用
收藏
页码:453 / 453
相关论文
共 50 条
  • [21] Chemotherapy in hormone-refractory prostate cancer
    Biedermann, B
    Pless, M
    Herrmann, R
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1999, 124 (28-29) : 874 - 879
  • [22] Anticancer effect of combination therapy of VP16 and fosfesterol in hormone-refractory prostate cancer
    Azuma, Haruhito
    Sakamoto, Takeshi
    Kiyama, Satoshi
    Ubai, Takanobu
    Kotake, Yatsugu
    Inamoto, Teruo
    Takahara, Kiyoshi
    Nishimura, Yasuichiro
    Segawa, Naoki
    Katsuoka, Yoji
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (02): : 188 - 194
  • [23] Weekly paclitaxel plus estramustine combination therapy in hormone-refractory prostate cancer: A pilot study
    Kuruma, H
    Fujita, T
    Shitara, T
    Egawa, S
    Yokoyama, E
    Baba, S
    INTERNATIONAL JOURNAL OF UROLOGY, 2003, 10 (09) : 470 - 475
  • [24] Gefitinib-trastuzumab combination on hormone-refractory prostate cancer xenograft
    Formento, P
    Hannoun-Levi, JM
    Gérard, F
    Mazeau, C
    Fischel, JL
    Etienne-Grimaldi, MC
    Gugenheim, J
    Milano, G
    EUROPEAN JOURNAL OF CANCER, 2005, 41 (10) : 1467 - 1473
  • [25] Combination Therapy with VP16 and Ethinylestradiol for Hormone-Refractory Prostate Cancer: Good Response with Tolerability
    Azuma, Haruhito
    Inamoto, Teruo
    Takahara, Kiyoshi
    Ibuki, Naokazu
    Koyama, Kohei
    Utimoto, Synya
    Fujisue, Yutaka
    Uehara, Hrohumi
    Komura, Kazumasa
    Nomi, Hayahito
    Ubai, Takanobu
    Katsuoka, Yoji
    ANTICANCER RESEARCH, 2010, 30 (09) : 3737 - 3746
  • [27] RETROSPECTIVE EVALUATION OF THERAPY WITH KETOCONAZOLE IN HORMONE-REFRACTORY PROSTATE CANCER (HRPC)
    Bonetta, Alberto
    Derelli, Roberto
    ANTICANCER RESEARCH, 2011, 31 (05) : 1942 - 1943
  • [28] Therapeutic Efficacy of Curcumin/TRAIL Combination Regimen for Hormone-Refractory Prostate Cancer
    Andrzejewski, Tanja
    Deeb, Dorrah
    Gao, Xiaohua
    Danyluk, Andrew
    Arbab, Ali S.
    Dulchavsky, Scott A.
    Gautam, Subhash C.
    ONCOLOGY RESEARCH, 2008, 17 (06) : 257 - 267
  • [29] Treatment with prednisolone of hormone-refractory prostate cancer
    Fuse, H
    Nozaki, T
    Fujiuchi, Y
    Mizuno, I
    Nagakawa, O
    Okumura, A
    ARCHIVES OF ANDROLOGY, 2006, 52 (01): : 35 - 38
  • [30] Octreotide in the management of hormone-refractory prostate cancer
    Vainas, IG
    CHEMOTHERAPY, 2001, 47 : 109 - 126